BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 19484450)

  • 1. Primary intraocular lymphoma presenting as an iris tumor.
    Im SK; Lee KH; Yoon KC
    Jpn J Ophthalmol; 2009 May; 53(3):274-5. PubMed ID: 19484450
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of primary B-cell type non-Hodgkin lymphoma originating in the iris.
    Yamada K; Hirata A; Kimura A; Tanihara H
    Am J Ophthalmol; 2003 Aug; 136(2):380-2. PubMed ID: 12888075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iris involvement by lymphoma: a review of 13 cases.
    Mashayekhi A; Shields CL; Shields JA
    Clin Exp Ophthalmol; 2013; 41(1):19-26. PubMed ID: 22594613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent systemic B cell lymphoma of the iris.
    Hykin PG; Shields JA; Shields CL; Ehya H; Siderides E
    Br J Ophthalmol; 1996 Oct; 80(10):929. PubMed ID: 8976711
    [No Abstract]   [Full Text] [Related]  

  • 5. Mantle cell lymphoma of the iris.
    Economou MA; Kopp ED; All-Ericsson C; Seregard S
    Acta Ophthalmol Scand; 2007 May; 85(3):341-3. PubMed ID: 17488468
    [No Abstract]   [Full Text] [Related]  

  • 6. Iris involvement in natural killer/T-cell lymphoma.
    Shimonagano Y; Nakao K; Sakamoto T; Uozumi K; Haraguchi K
    Jpn J Ophthalmol; 2006; 50(6):557-558. PubMed ID: 17180534
    [No Abstract]   [Full Text] [Related]  

  • 7. Iris involvement in primary intraocular lymphoma: report of two cases and review of the literature.
    Velez G; de Smet MD; Whitcup SM; Robinson M; Nussenblatt RB; Chan CC
    Surv Ophthalmol; 2000; 44(6):518-26. PubMed ID: 10906383
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional rituximab for primary iris lymphoma.
    Demirci H; Grant JS; Elner VM
    JAMA Ophthalmol; 2015 Jan; 133(1):104-5. PubMed ID: 25211092
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intravitreal chemotherapy for intraocular lymphoma].
    Helbig H; Cerny T; de Smet MD
    Ophthalmologe; 2003 Feb; 100(2):145-9. PubMed ID: 12589460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of primary CNS lymphoma with high-dose methotrexate in immunocompetent pediatric patients.
    Shah AC; Kelly DR; Nabors LB; Oakes WJ; Hilliard LM; Reddy AT
    Pediatr Blood Cancer; 2010 Dec; 55(6):1227-30. PubMed ID: 20882580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bilateral iridociliary T-cell lymphoma.
    Yahalom C; Cohen Y; Averbukh E; Anteby I; Amir G; Pe'er J
    Arch Ophthalmol; 2002 Feb; 120(2):204-7. PubMed ID: 11831925
    [No Abstract]   [Full Text] [Related]  

  • 12. Iris lymphoma in a pediatric cardiac transplant recipient: clinicopathologic findings.
    Chan SM; Hutnik CM; Heathcote JG; Orton RB; Banerjee D
    Ophthalmology; 2000 Aug; 107(8):1479-82. PubMed ID: 10919894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An Asian patient with intraocular lymphoma treated by intravitreal methotrexate.
    Wang JK; Yang CM; Lin CP; Shan YD; Lo AY; Tien HF
    Jpn J Ophthalmol; 2006; 50(5):474-478. PubMed ID: 17013703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of primary intraocular lymphoma with intravitreal methotrexate.
    Sou R; Ohguro N; Maeda T; Saishin Y; Tano Y
    Jpn J Ophthalmol; 2008; 52(3):167-174. PubMed ID: 18661266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement.
    Smith JR; Rosenbaum JT; Wilson DJ; Doolittle ND; Siegal T; Neuwelt EA; Pe'er J
    Ophthalmology; 2002 Sep; 109(9):1709-16. PubMed ID: 12208721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of primary intraocular lymphoma (PIOL) has involved systemic, intravitreal or intrathecal chemotherapy and/or radiotherapy.
    Itty S; Olson JH; O'Connell DJ; Pulido JS
    Retina; 2009 Mar; 29(3):415-6. PubMed ID: 19174721
    [No Abstract]   [Full Text] [Related]  

  • 17. Iris melanoma management with iodine-125 plaque radiotherapy in 144 patients: impact of melanoma-related glaucoma on outcomes.
    Shields CL; Shah SU; Bianciotto CG; Emrich J; Komarnicky L; Shields JA
    Ophthalmology; 2013 Jan; 120(1):55-61. PubMed ID: 22980742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Iris seeding following iridocyclectomy for localised iris melanoma.
    Gupta M; Puri P; Rennie IG
    Eye (Lond); 2001 Dec; 15(Pt 6):808-9. PubMed ID: 11827017
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary intraocular lymphoma: current and future perspectives.
    Dunleavy K; Wilson WH
    Leuk Lymphoma; 2006 Sep; 47(9):1726-7. PubMed ID: 17064977
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of 2-methoxyestradiol and methotrexate effects on non-Hodgkin's B-cell lymphoma.
    Park J; Franco RS; Augsburger JJ; Banerjee RK
    Curr Eye Res; 2007; 32(7-8):659-67. PubMed ID: 17852190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.